Context Therapeutics Inc.
CNTX • NASDAQ
Context Therapeutics Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Martin A. Lehr, with a market cap of $238.0M.
Market Cap$238.0M
Employees9.0
CEOMartin A. Lehr
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 6, 2026 · In 3 weeksQ1 2026
Financials
Context Therapeutics Inc. FAQ
Common questions about Context Therapeutics Inc.
Context Therapeutics Inc. is scheduled to report earnings for Q1 2026 on May 6, 2026.
Context Therapeutics Inc. has approximately 9 employees.